U.S. federal trademark · Serial No. 79194198 · Reg. No. 5372047
Pharmaceuticals, namely, plasma derived and recombinant immunoglobulins; pharmaceuticals, namely, plasma derived and recombinant proteins for treating pulmonary diseases, congenital Alpha-1 Antitrypsin deficiency, post-exposure prophylaxis against viral infection, preventing and treating immune tolerance based diseases, treating immunological disorders, and treating inflammatory diseases; pharmaceuticals, namely, coagulation factors for bleeding disorders; plasma-derived protein preparations for therapeutic use; vaccines; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for the treatment or prevention of thrombo-embolic disorders; pharmaceutical preparations for anesthesia or analgesia for surgery
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.